Posted by Michael Wonder on 16 Jun 2025
EMA publishes agenda for 16-19 June 2025 CHMP meeting
16 June 2025 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Aflibercept
- Deutetrabenazine
- Tenofovir alafenamide fumarate with emtricitabine and rilpivirine
- Sargramostim
- Nintedanib esylate
- Nirogacestat
- Resmetiron
- Ustekinumab
- Dorocubicel
